FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs. The interim staff report, which is part of an ongoing inquiry launched in 2022 by the FTC, details how ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB1 day ago · Sept. 20, 2024. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin ...
Federal Trade Commission sues largest drug middlemen for
WEB1 day ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
FTC sues pharmacy benefit managers for inflating price of insulin : …
WEB7 hours ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
FTC sues drug middlemen for allegedly inflating insulin prices
WEB1 day ago · The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while “artificially ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB1 day ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
FTC sues insulin middlemen, saying they pocket billions while …
WEB7 hours ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
FTC Further Expands Inquiry Into Prescription Drug Middlemen …
WEBJun 8, 2023 · As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory order to a third group purchasing organization (GPO) that negotiates drug rebates on behalf of PBMs.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
WEB1 day ago · Photo: Zuma Press. The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on ...
Skip to content